Based on 2 reference(s) in Google Scholar 8 10 2

Axon 3701

CAS [2051587-62-1]

MF C28H29NO6
MW 475.53

  • Purity: 97%
  • Soluble in DMSO and EtOH



SL-145 is a C-terminal heat shock protein 90 (HSP90) inhibitor. SL-145 elicits anti-tumor and anti-metastatic effects without triggering the heat shock response (HSR) due to its unconventional targeting of the C-terminal region. SL-145 simultaneously inhibits multiple oncogenic signaling pathways including AKT, MEK/ERK, and JAK2/STAT3 in vitro and in vivo.

KEYWORDS: SL-145 | Supplier | HSP90 inhibitor | SL145 | SL 145 | CAS [2051587-62-1] | Unfolded protein response (Non selective) | Hsp90 | Inhibitor | Enzymes | Heat shock protein 90 | Metastatic triple-negative breast cancer | TNBC | Antiangiogenic

Size Unit Price Stock
5 mg €120.00 In Stock
25 mg €480.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...